Our commitment to keeping you safe
We have never taken for granted the sacred trust you place in us to care for your child, and today we are more grateful than ever for that privilege. To learn about all the ways we are working to keep you, your family and our team members safe, visit our COVID-19 updates page.
As the largest cancer and blood disease program in North Texas, and one of the largest in the U.S., Children’s Health℠ provides care for more than 350 children with newly-diagnosed cancer and more than 600 children with newly-diagnosed blood disease each year.
Children’s Health is the only pediatric cancer program affiliated with the UT Southwestern Harold C. Simmons Comprehensive Cancer Center. As the only National Cancer Institute-designated comprehensive cancer center in North Texas, we are always pushing to discover new treatments. We offer patients the ability to participate in the broadest possible range of clinical trials, giving access to potential therapies not available at other facilities.
When Briana Ayala came to Children’s Health, she had a tumor that wouldn’t stop growing around her aorta. Then we found its Achilles’ heel: an NTRK-2 gene fusion that was potentially susceptible to a drug called larotrectinib. Read more »
Children’s Health and UT Southwestern part of a research collaboration that’s using patient-derived xenografts to pursue targeted therapies for an array of pediatric cancers. Read more »
Gut-health research could help reduce infections in stem cell transplant patients, modulate GVHD and make cancer immunotherapy more effective. Read more »
This study aims to evaluate the safety and feasibility of UCART19 to induce molecular remission in pediatric patients with relapsed or refractory CD19-positive B-cell acute lymphoblastic leukemia (B-ALL). Learn more
Many of our conferences and events offer continuing education credits.
After the Cancer Experience (ACE) is the first and largest cancer survivor program in North Texas that bridges medical care from childhood to adult life within a centralized medical system. Learn more.
Dr. Laetsch spearheaded the creation of the Experimental Therapeutics Program (ETP) at the Pauline Allen Gill Center for Cancer and Blood Disorders at Children’s Health. The program brings innovative therapies to children with a wide variety of cancers.
As the ETP’s Director, Dr. Laetsch serves as Principal Investigator of more than a dozen Phase I and Phase II trials of novel agents for children with relapsed or refractory cancer.
